Catheter Precision, Inc. (VTAK) Form 8-K — May 18, 2026
Catheter Precision reported Q1 2026 revenue of $432,000, representing a 200% year-over-year increase from $143,000 in the prior year period. This growth was driven by a 73% increase in its core medical device segment and the immediate revenue contribution from its newly acquired aviation platform, Flyte. The company’s net loss narrowed significantly to $1.7 million from $4.0 million in Q1 2025, aided by operating discipline and revenue scaling. Flyte, which operates through FAA-certified carrier Ponderosa Air, LLC, achieved a $200,000 monthly revenue run rate within 22 days of post-acquisition operations and has expanded its fleet to three aircraft.
Key figures
- Revenue
- 432000
- Revenue Yoy
- 200%
- Q1 2025 revenue
- 143000
- Flyte fleet size
- 3
- Q1 2025 net loss
- -4000000
- Non cash expenses
- 560000
- Flyte monthly run rate
- 200000
- Medical device revenue growth
- 73%
Price after filing
Close on the filing date to close N calendar days later (from $0.83). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.